Status:
ACTIVE_NOT_RECRUITING
Pediatric HIV Disclosure Benefits Study (PhD-BS) - Sankofa 2
Lead Sponsor:
Boston University
Collaborating Sponsors:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Conditions:
HIV
Eligibility:
All Genders
7-18 years
Phase:
NA
Brief Summary
The purpose of this study is to conduct a pragmatic, stepped wedge cluster randomized trial in 12 HIV pediatric clinics in Ghana to determine effectiveness, health benefits, cost and implementation to...
Detailed Description
In this 5-year study, the investigators would like to build upon the successful Sankofa trial by testing the intervention in a larger scale study delivered in "real-world" clinic conditions over time ...
Eligibility Criteria
Inclusion
- HIV infected children
- Children between the ages of 7-18 who do not know their HIV diagnosis (based on caregiver account and medical records confirmation) and their caregivers will be eligible to participate in the study
Exclusion
- HIV-infected children less than 7 years
- HIV-infected children with congenital or developmental disorders
- HIV-infected children with comorbidities such as sickle cell disease or diabetes that require frequent clinic visits or hospitalizations
- Children with AIDS-defining illness or end stage AIDS.
Key Trial Info
Start Date :
June 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2026
Estimated Enrollment :
747 Patients enrolled
Trial Details
Trial ID
NCT04791865
Start Date
June 15 2021
End Date
March 1 2026
Last Update
February 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Korle-Bu Teaching Hospital
Accra, Ghana